Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal (2025-12-24)
Sanofi will buy U.S. vaccines company Dynavax Technologies for around $2.2 billion (1.9 billion euros), the ‍French drugmaker said on Wednesday.